Mortality comparison between axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SND) among breast cancer pantient: A meta-analysis and systematic review study

被引:0
作者
Herida, Alifia Ramadhani [1 ]
Dewi, Sari Puspita [1 ]
Herida, Akmal Fauzan [1 ]
机构
[1] Univ Sebelas Maret, Fac Med, Surakarta, Central Java, Indonesia
关键词
axillary lymph node dissection; breast cancer; mortality; sentinel lymph node biopsy; TRIAL; MORBIDITY; WOMEN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Axillary lymph node dissection (ALND) is a crucial surgical procedure for breast cancer. It has guaranteed locoregional control of the disease, guided adjuvant therapy, and functioned as a staging tool. However, over the past 25 years, a more conservative approach has become the standard for surgical management of the axilla. Because sentinel lymph node biopsy (SNB) is less invasive and less morbid than axillary lymph node dissection (ALND), it has become the standard surgical procedure for axillary staging of clinically node-negative breast cancer. This study aimed to compare the mortality of breast cancer patients receiving ALND and SNB procedure. Methods: Our review includes randomized controlled trials of breast cancer patients undergoing ALND or SNB surgical techniques. A systematic literature search was performed from PubMed on December 2023 to search for articles reporting on survival rates between ALND vs SNB among breast cancer patients. The data obtained then underwent statistical evaluation, and a meta-analysis was conducted using Review Manager 5.4. In order to represent primary outcomes, the risk ratio was estimated using an inverse variance technique with a random-effects model. Heterogeneity was presented with total values, 95% confidence intervals (CI), and I values. Results: As many as 208 articles were found in the PubMed database search, and only six studies were included in this study. The six included trials all used chemotherapy and radiotherapy for systematic treatment. The length of follow-up varied from 33 months to 15 years. The total number of patients in the trials was 3,585, and the study period was from 2011 to 2023. The pooled analysis of the mortality outcomes showed that the heterogeneity of the data was low (I2 21%, p = 0.4). In the pooled analysis, the mortality of patients with SNB for surgical treatment was not significantly different compared to patients with ALND (OR:0.88; 95% CI:0.65-1.19). Conclusion: The mortality of patients undergoing SNB and ALND does not differ significantly, according to this pooled study. It demonstrates that the group without axillary dissection had a primary survival outcome that was not inferior to that of the dissection group.
引用
收藏
页码:895 / 899
页数:5
相关论文
共 21 条
  • [1] [Anonymous], 2003, NEW ENGL J MED, V7, P546
  • [2] SURGICAL MORBIDITY AFTER MASTECTOMY OPERATIONS
    BUDD, DC
    COCHRAN, RC
    STURTZ, DL
    FOUTY, WJ
    [J]. AMERICAN JOURNAL OF SURGERY, 1978, 135 (02) : 218 - 220
  • [3] Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial
    Canavese, Giuseppe
    Bruzzi, Paolo
    Catturich, Alessandra
    Tomei, Daniela
    Carli, Franca
    Garrone, Elsa
    Spinaci, Stefano
    Lacopo, Federico
    Tinterri, Corrado
    Dozin, Beatrice
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (08) : 2494 - 2500
  • [4] Cc S, 1974, SURG GYNECOL OBSTET
  • [5] Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled, phase 3 trial
    Galimberti, Viviana
    Cole, Bernard F.
    Viale, Giuseppe
    Veronesi, Paolo
    Vicini, Elisa
    Intra, Mattia
    Mazzarol, Giovanni
    Massarut, Samuele
    Zgajnar, Janez
    Taffurelli, Mario
    Littlejohn, David
    Knauer, Michael
    Tondini, Carlo
    Di Leo, Angelo
    Colleoni, Marco
    Regan, Meredith M.
    Coates, Alan S.
    Gelber, Richard D.
    Goldhirsch, Aron
    [J]. LANCET ONCOLOGY, 2018, 19 (10) : 1385 - 1393
  • [6] Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial
    Giuliano, Armando E.
    Hunt, Kelly K.
    Ballman, Karla V.
    Beitsch, Peter D.
    Whitworth, Pat W.
    Blumencranz, Peter W.
    Leitch, A. Marilyn
    Saha, Sukamal
    McCall, Linda M.
    Morrow, Monica
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (06): : 569 - 575
  • [7] Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
    Goldhirsch, A.
    Winer, E. P.
    Coates, A. S.
    Gelber, R. D.
    Piccart-Gebhart, M.
    Thuerlimann, B.
    Senn, H. -J.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (09) : 2206 - 2223
  • [8] NCCN Guidelines® Insights Breast Cancer, Version 1.2017 Featured Updates to the NCCN Guidelines
    Gradishar, William J.
    Anderson, Benjamin O.
    Balassanian, Ron
    Blair, Sarah L.
    Burstein, Harold J.
    Cyr, Amy
    Elias, Anthony D.
    Farrar, William B.
    Forero, Andres
    Giordano, Sharon Hermes
    Goetz, Matthew P.
    Goldstein, Lori J.
    Isakoff, Steven J.
    Lyons, Janice
    Marcom, P. Kelly
    Mayer, Ingrid A.
    McCormick, Beryl
    Moran, Meena S.
    O'Regan, Ruth M.
    Patel, Sameer A.
    Pierce, Lori J.
    Reed, Elizabeth C.
    Salerno, Kilian E.
    Schwartzberg, Lee S.
    Sitapati, Amy
    Smith, Karen Lisa
    Smith, Mary Lou
    Soliman, Hatem
    Somlo, George
    Telli, Melinda
    Ward, John H.
    Shead, Dorothy A.
    Kumar, Rashmi
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (04): : 433 - +
  • [9] Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons oncology Group trial Z0011
    Lucci, Anthony
    McCall, Linda Mackie
    Beitsch, Peter D.
    Whitworth, Patrick W.
    Reintgen, Douglas S.
    Blumencranz, Peter W.
    Leitch, A. Marilyn
    Saha, Sukumal
    Hunt, Kelly K.
    Giuliano, Armando E.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3657 - 3663
  • [10] Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: The ALMANAC trial
    Mansel, RE
    Fallowfield, L
    Kissin, M
    Goyal, A
    Newcombe, RG
    Dixon, JM
    Yiangou, C
    Horgan, K
    Bundred, N
    Monypenny, I
    England, D
    Sibbering, M
    Abdullah, TJ
    Barr, L
    Chetty, U
    Sinnett, DH
    Fleissig, A
    Clarke, D
    Ell, PJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (09) : 599 - 609